Symbols
Symbols
Aime
Products
News
Markets
Watchlist
Brokers
How did PTGX's Q4 2023 earnings surprise analysts?
4/7/2025 11:12am
Protagonist Therapeutics Inc (PTGX) exceeded analysts' expectations in Q4 2023, with a net income surprise of $0.47 million and a revenue surprise of $20 million.
Aime finds your next big stock
Aime powers your decisions